Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease

被引：0
|
作者：
JA Huapaya
KD Wiley
SK Danoff
机构：
[1] University of Maryland,Division of Pulmonary and Critical Care Medicine
[2] National Institutes of Health,Division of Critical Care Medicine
[3] Malcolm Grow Medical Center,Department of Internal Medicine
[4] Johns Hopkins University School of Medicine,Division of Pulmonary and Critical Care Medicine
来源：
Current Treatment Options in Rheumatology | 2021年 / 7卷
关键词：
Antisynthetase syndrome; Idiopathic inflammatory myopathies; Immunosuppressive therapy; Interstitial lung disease; Treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：243 / 257
页数：14
相关论文
共 50 条
  • [1] Treatment in Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Wiley, K. D.
    Danoff, S. K.
    [J]. CURRENT TREATMENT OPTIONS IN RHEUMATOLOGY, 2021, 7 (03) : 243 - 257
  • [2] Cyclophosphamide For Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Huapaya, J. A.
    Silhan, L. L.
    Danoff, S. K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [3] A Review of Antisynthetase Syndrome-Associated Interstitial Lung Disease
    Patel, Puja
    Marinock, Jenna M.
    Ajmeri, Aamir
    Brent, Lawrence H.
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (08)
  • [4] Long-term treatment with human immunoglobulin for antisynthetase syndrome-associated interstitial lung disease
    Huapaya, J. A.
    Hallowell, R.
    Silhan, L.
    Pinal-Fernandez, I.
    Casal-Dominguez, M.
    Johnson, C.
    Albayda, J.
    Paik, J. J.
    Lin, C. T.
    Hussien, A.
    Mammen, A. L.
    Christopher-Stine, L.
    Danoff, S. K.
    [J]. RESPIRATORY MEDICINE, 2019, 154 : 6 - 11
  • [5] Rituximab in the Treatment of Interstitial Lung Disease Associated with the Antisynthetase Syndrome
    Narvaez, Javier
    Canadillas-Sanchez, Elena
    Castellvi, Ivan
    Jose Alegre, Juan
    Vidal-Montal, Paola
    Miquel Nolla, Joan
    [J]. ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 2308 - 2309
  • [6] Antisynthetase Syndrome-Associated Interstitial Lung Disease: Monitoring of Immunosuppressive Treatment Effects by Chest Computed Tomography
    Korsten, Peter
    Rademacher, Jan-Gerd
    Riedel, Linn
    Schnitzler, Eva-Maria
    Olgemoller, Ulrike
    Seitz, Cornelia Sabine
    Schmidt, Jens
    Larsen, Jorg
    Vasko, Radovan
    [J]. FRONTIERS IN MEDICINE, 2021, 7
  • [7] Rituximab in the treatment of progressive interstitial lung disease associated with the antisynthetase syndrome
    Narvaez, Javier
    Canadillas, Elena
    Castellvi, Ivan
    Alegre, Juan Jose
    Vincens-Zygmunt, Vanesa
    Bermudo, Guadalupe
    Vidal-Montal, Paola
    Molina Molina, Maria
    Nolla, Joan Miquel
    [J]. ARTHRITIS RESEARCH & THERAPY, 2024, 26 (01)
  • [8] Fanconi syndrome-associated interstitial lung disease
    Papaioannou, Ourania
    Karampitsakos, Theodoros
    Sampsonas, Fotios
    Tzouvelekis, Argyrios
    [J]. BMJ CASE REPORTS, 2022, 15 (07)
  • [9] Assessment of the Effect of Rituximab in the Treatment of Interstitial Lung Disease associated with the Antisynthetase Syndrome.
    Doyle, Tracy
    Osorio, Juan
    DeMagaldi, Eduarda Nilo
    Madan, Rachna
    Cabral, Fernanda
    Rosas, Ivan
    Dellaripa, Paul
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S557 - S558
  • [10] Treatment of antisynthetase-associated interstitial lung disease with tacrolimus
    Wilkes, MR
    Sereika, SM
    Fertig, N
    Lucas, MR
    Oddis, CV
    [J]. ARTHRITIS AND RHEUMATISM, 2005, 52 (08): : 2439 - 2446
12345